DCS Europe to topple £150m turnover target

Posted on 20 Feb 2013

Health and beauty products manufacturer DCS Europe has increased its lending facility to up to £32m.

Barclays increased the lending level from £19m to £32m with Jim Quantrill from Barclays Corporate Banking stating that DCS is “on target to achieve their ambitious turnover target of £150 million this year.”

DCS is the official UK distributor for Procter & Gamble, Unilever, Colgate and many more. The company’s own brand ‘Enliven’, which consists of a range of 75 products, is produced in their new factory as well as the manufacturing of a number of own-label products on behalf of retailers such as Superdrug, Next and Wilkinsons.

The company invested £500,000 last year into expanding the fastest areas of its business: manufacturing, export, high street discount and repacking.

In the last three years sales have increased by over £40 million in these areas.

DCS is the UK’s largest privately owned health and beauty company and is based in Stratford-upon-Avon employing 250 people.

CEO Denys Shortt was awarded an OBE in recognition of his business achievements this year.

“We are continuing to grow the business further following investment in our facility in Stratford last year and we will continue to develop all areas of the business to create jobs and growth.”